The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
<h4>Background</h4>North-west Ethiopia faces the highest burden world-wide of visceral leishmaniasis (VL) and HIV co-infection. VL-HIV co-infected patients have higher (initial) parasitological failure and relapse rates than HIV-negative VL patients. Whereas secondary prophylaxis reduces...
Saved in:
| Main Authors: | Charles Abongomera, Ermias Diro, Alan de Lima Pereira, Jozefien Buyze, Kolja Stille, Fareed Ahmed, Johan van Griensven, Koert Ritmeijer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-05-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0006527&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liposomal amphotericin B (AmBisome®) pharmacokinetics: Reaching the skin, review of the literature, and a case series of treated severe disfiguring post kala-azar dermal leishmaniasis
by: Eltahir Awad Gasim Khalil, et al.
Published: (2025-06-01) -
Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.
by: Saskia van Henten, et al.
Published: (2021-05-01) -
Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial.
by: Eltahir A G Khalil, et al.
Published: (2014-01-01) -
Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.
by: Sabrina Cencig, et al.
Published: (2011-06-01) -
Foamy histiocytes in a patient with visceral leishmaniasis after treatment with liposomal amphotericin B
by: Betül Tavil, et al.
Published: (2008-02-01)